beta-lapachone has been researched along with gentian violet in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bombaça, AC; Cardoso, MFDC; Cavaleiro, JAS; da Rocha, DR; da Silva, FC; de Castro, SL; Ferreira, VF; Salomão, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Camara, CA; Costa, VA; da Silva Júnior, EN; de Araujo, AS; de Castro, SL; de Melo, IM; de Oliveira, RN; de Simone, CA; de Souza Filho, JD; Diogo, EB; dos Santos, MR; Emery, FS; Menna-Barreto, RF; Valença, WO | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
4 other study(ies) available for beta-lapachone and gentian violet
| Article | Year |
|---|---|
Synthesis and anti-Trypanosoma cruzi activity of new 3-phenylthio-nor-β-lapachone derivatives.
Topics: Animals; Benzofurans; Cell Survival; Cells, Cultured; Chagas Disease; Embryo, Mammalian; Heart; Humans; Mice; Myocardium; Naphthoquinones; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
Topics: Animals; Chemistry Techniques, Synthetic; Click Chemistry; Drug Discovery; Mice; Naphthoquinones; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |